skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Proinflammatory cytokines differentially influence adult hippocampal cell proliferation depending upon the route and chronicity of administration

Original Research

(2775) Views  (558) Full article downloads

Authors: Julie Anne Seguin, Jordan Brennan, Emily Mangano, Shawn Hayley

Published Date December 2008 Volume 2009:5 Pages 5 - 14
DOI: http://dx.doi.org/10.2147/NDT.S4476

Julie Anne Seguin, Jordan Brennan, Emily Mangano, Shawn Hayley

Institute of Neuroscience, Carleton University, Ottawa, Ontario, Canada

Abstract: Disturbances of hippocampal plasticity, including impaired dendritic branching and reductions of neurogenesis, are provoked by stressful insults and may occur in depression. Although corticoids likely contribute to stressor-induced reductions of neurogenesis, other signaling messengers, including pro-inflammatory cytokines might also be involved. Accordingly, the present investigation assessed whether three proinflammatory cytokines, namely interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α) (associated with depression) influenced cellular proliferation within the hippocampus. In this regard, systemic administration of TNF-α reduced 5-bromo-2-deoxyuridine (BrdU) labeling within the hippocampus, whereas IL-1β and IL-6 had no such effect. However, repeated but not a single intra-hippocampal infusion of IL-6 and IL-1β actually increased cellular proliferation and IL-6 infusion also enhanced microglial staining within the hippocampus. Yet, no changes in doublecortin expression were apparent, suggesting that the cytokine did not influence the birth of cells destined to become neurons. Essentially, the route of administration and chronicity of cytokine administration had a marked influence upon the nature of hippocampal alterations provoked, suggesting that cytokines may differentially regulate hippocampal plasticity in neuropsychiatric conditions.

Keywords: cytokine, depression, neuroplasticity, hippocampus, stressor








Readers of this article also read:

Duloxetine for the treatment of generalized anxiety disorder: a review
Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
Treatment of refractory complex partial seizures: role of vigabatrin
Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
Coenzyme Q10 effects in neurodegenerative disease
Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine
Recent advances in the management of chronic stable angina I: Approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities
Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model
Implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania
The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregation